Climb Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Climb Bio and other ETFs, options, and stocks.About CLYM
Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases.
CEOAoife M. Brennan
CEOAoife M. Brennan
Employees18
Employees18
HeadquartersWellesley Hills, Massachusetts
HeadquartersWellesley Hills, Massachusetts
Founded2018
Founded2018
Employees18
Employees18
CLYM Key Statistics
Market cap226.94M
Market cap226.94M
Price-Earnings ratio-4.00
Price-Earnings ratio-4.00
Dividend yield—
Dividend yield—
Average volume1.29M
Average volume1.29M
High today$3.25
High today$3.25
Low today$2.25
Low today$2.25
Open price$2.31
Open price$2.31
Volume8.38M
Volume8.38M
52 Week high$3.25
52 Week high$3.25
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
With a market cap of 226.94M, Climb Bio(CLYM) trades at $3.07. The stock has a price-to-earnings ratio of -4.00.
During the trading session on 2025-12-15, Climb Bio(CLYM) shares reached a daily high of $3.25 and a low of $2.25. At a current price of $3.07, the stock is +36.4% higher than the low and still -5.5% under the high.
Trading volume for Climb Bio(CLYM) stock has reached 8.38M, versus its average volume of 1.29M.
Over the past 52 weeks, Climb Bio(CLYM) stock has traded between a high of $3.25 and a low of $1.05.
Over the past 52 weeks, Climb Bio(CLYM) stock has traded between a high of $3.25 and a low of $1.05.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CLYM. This list is generated using Robinhood data, and it’s not a recommendation.